文献速递肾小球疾病遗传性与小管间质肾病

COL4A3、COL4A4和COL4A5基因变异与散发性IgA肾病患者肾小球基底膜变薄病变相关

Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.
PubMed 文献 · J Am Soc Nephrol · 2022-10-05

该研究比较了161例伴肾小球基底膜变薄(tGBM)的散发性IgA肾病患者与匹配的无tGBM的IgA肾病患者及薄基底膜肾病患者,通过全外显子测序筛查COL4A3/COL4A4/COL4A5基因变异。在122例伴tGBM的IgA肾病患者中,38例(31.1%)检出37个诊断性变异;携带诊断性变异者基底膜厚度<250 nm比例更高且肾小球损伤更轻,而不携带者IgA沉积更强且Gd-IgA1水平升高。作者认为,对伴tGBM病变的散发性IgA肾病患者,检测COL4A3/COL4A4/COL4A5变异是评估所必需的。

要点

  • 伴tGBM的散发性IgA肾病患者疾病表现较无tGBM者轻,但较薄基底膜肾病患者重。
  • 122例伴tGBM的IgA肾病患者中38例(31.1%)检出COL4A3/COL4A4/COL4A5诊断性变异。
  • 携带诊断性变异者基底膜厚度<250 nm比例更高且肾小球损伤更轻,不携带者IgA沉积更强、Gd-IgA1升高。

核心结论

  • COL4A3/COL4A4/COL4A5变异检测对评估伴tGBM病变的散发性IgA肾病患者是必需的。
  • 携带与不携带这些胶原基因诊断性变异的患者可能存在不同机制。

研究设计与样本

  • 比较161例伴tGBM的散发性IgA肾病患者与匹配的无tGBM的IgA肾病患者及匹配的薄基底膜肾病患者。
  • 对COL4A3/COL4A4/COL4A5基因变异进行全外显子测序筛查与评估,测量GBM厚度,并用ELISA检测循环Gd-IgA1水平。

主要发现

  • 伴tGBM的IgA肾病患者疾病表现较无tGBM的IgA肾病患者轻,但较薄基底膜肾病患者重。
  • 对122例伴tGBM的IgA肾病患者行外显子序列分析,在38例(31.1%)中鉴定出37个COL4A3/COL4A4/COL4A5诊断性变异。
  • 携带诊断性变异的伴tGBM的IgA肾病患者中GBM厚度<250 nm的比例更高且肾小球损伤更轻。
  • 不携带诊断性变异的伴tGBM的IgA肾病患者表现出更典型的IgA肾病特征,包括肾小球IgA沉积强度更高和Gd-IgA1水平升高。

关键数值与推荐

  • 在122例伴tGBM的IgA肾病患者中,38例(31.1%)检出37个COL4A3/COL4A4/COL4A5诊断性变异。
  • 携带诊断性变异者GBM厚度<250 nm的比例更高且肾小球损伤更轻;不携带者肾小球IgA沉积强度更高、Gd-IgA1水平升高。

临床怎么用

  • 作者认为,对伴tGBM病变的散发性IgA肾病患者,检测COL4A3/COL4A4/COL4A5变异是评估所必需的。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thinned glomerular basement membrane (tGBM) lesions are not uncommon in IgA nephropathy (IgAN). Type IV collagen-built of α 3, α 4, and α 5 chains, encoded by COL4A3 / COL4A4 / COL4A5 genes-is the major component of glomerular basement membrane (GBM). In recent years, mutations in type IV collagen-encoding genes were also reported in patients with a histologic diagnosis of FSGS. Pathogenic COL4A3 / COL4A4 / COL4A5 variants were recently identified in familial cases of IgAN, but the contribution of these variants to sporadic IgAN is still unclear. METHODS: We compared 161 patients with sporadic IgAN with tGBM lesions (IgAN-tGBM) to matched patients with IgAN without tGBM lesions and matched patients with thin basement membrane nephropathy (TBMN). Variants of COL4A3 / COL4A4 / COL4A5 genes were screened and evaluated after whole-exome sequencing. GBM thickness was measured, and levels of circulating galactose-deficient IgA1 (Gd-IgA1) were assessed by ELISA. RESULTS: The patients with IgAN-tGBM manifested milder disease than did patients with IgAN without tGBM but had more severe features than the patients with TBMN. Exome sequence analysis of the 122 patients with IgAN-tGBM identified 37 diagnostic variants of the COL4A3 / COL4A4 / COL4A5 genes among 38 patients (31.1%). Furthermore, patients with IgAN-tGBM who had diagnostic variants had higher proportions of GBM thickness <250 nm and milder glomerular injury, whereas patients with IgAN-tGBM who did not have diagnostic variants showed more characteristic features of IgAN, including higher intensity of glomerular IgA deposits and elevated Gd-IgA1 levels. These findings suggest different mechanisms in patients with versus without diagnostic variants of these collagen genes. CONCLUSIONS: COL4A3 / COL4A4 / COL4A5 variant detection is essential in evaluating patients with sporadic IgAN with tGBM lesions.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Yuan X, Su Q, Wang H, et al. Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients. J Am Soc Nephrol. 2022. PMID: 36130833. doi:10.1681/ASN.2021111447

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。